溴丙胺太林雜質(zhì)Ⅱ(呫噸酸)
|
PCL-#-Chp0454-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
82-07-5 |
50mg
|
咨詢
|
咨詢 |
PCL |
溴丙胺太林雜質(zhì)Ⅱ(呫噸酸)
|
PCL-#-Chp0454-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
82-07-5 |
25mg
|
咨詢
|
咨詢 |
PCL |
溴丙胺太林雜質(zhì)Ⅰ(9-羥基溴丙胺太林)
|
PCL-#-Chp0453-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
93446-02-7 |
50mg
|
咨詢
|
咨詢 |
PCL |
溴丙胺太林雜質(zhì)Ⅰ(9-羥基溴丙胺太林)
|
PCL-#-Chp0453-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
93446-02-7 |
25mg
|
咨詢
|
咨詢 |
PCL |
雷米普利雜質(zhì)Ⅵ(雷米普利二酮哌嗪酸)
|
PCL-#-Chp0452-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
108736-10-3 |
50mg
|
咨詢
|
咨詢 |
PCL |
雷米普利雜質(zhì)Ⅵ(雷米普利二酮哌嗪酸)
|
PCL-#-Chp0452-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
108736-10-3 |
25mg
|
咨詢
|
咨詢 |
PCL |
雷米普利雜質(zhì)Ⅴ(雷米普利拉)
|
PCL-#-Chp0451-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
87269-97-4 |
50mg
|
咨詢
|
咨詢 |
PCL |
雷米普利雜質(zhì)Ⅴ(雷米普利拉)
|
PCL-#-Chp0451-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
87269-97-4 |
25mg
|
咨詢
|
咨詢 |
PCL |
雷米普利雜質(zhì)Ⅳ(雷米普利二酮哌嗪)
|
PCL-#-Chp0450-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
108731-95-9 |
50mg
|
咨詢
|
咨詢 |
PCL |
雷米普利雜質(zhì)Ⅳ(雷米普利二酮哌嗪)
|
PCL-#-Chp0450-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
108731-95-9 |
25mg
|
咨詢
|
咨詢 |
PCL |
雷米普利雜質(zhì)Ⅲ(環(huán)己基雷米普利)
|
PCL-#-Chp0449-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
99742-35-5 |
50mg
|
咨詢
|
咨詢 |
PCL |
雷米普利雜質(zhì)Ⅲ(環(huán)己基雷米普利)
|
PCL-#-Chp0449-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
99742-35-5 |
25mg
|
咨詢
|
咨詢 |
PCL |
雷米普利雜質(zhì)Ⅱ(雷米普利異丙酯)
|
PCL-#-Chp0448-50mg
|
≥95%,雜質(zhì)對(duì)照品 |
295328-72-2 |
50mg
|
¥ 4000.0
|
1-2周 |
PCL |
雷米普利雜質(zhì)Ⅱ(雷米普利異丙酯)
|
PCL-#-Chp0448-25mg
|
≥95%,雜質(zhì)對(duì)照品 |
295328-72-2 |
25mg
|
¥ 1500.0
|
1-2周 |
PCL |
雷米普利雜質(zhì)Ⅰ(雷米普利甲酯)
|
PCL-#-Chp0447-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
108313-11-7 |
50mg
|
咨詢
|
咨詢 |
PCL |
雷米普利雜質(zhì)Ⅰ(雷米普利甲酯)
|
PCL-#-Chp0447-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
108313-11-7 |
25mg
|
咨詢
|
咨詢 |
PCL |
雷貝拉唑鈉雜質(zhì)Ⅲ(2-[[[4-(3-甲氧基丙氧基)-3-甲基吡啶-2-基]甲基]硫代]-1H-苯并咪唑 )
|
PCL-#-Chp0446-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
117977-21-6 |
50mg
|
咨詢
|
咨詢 |
PCL |
雷貝拉唑鈉雜質(zhì)Ⅲ(2-[[[4-(3-甲氧基丙氧基)-3-甲基吡啶-2-基]甲基]硫代]-1H-苯并咪唑 )
|
PCL-#-Chp0446-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
117977-21-6 |
25mg
|
咨詢
|
咨詢 |
PCL |
雷貝拉唑鈉雜質(zhì)Ⅱ(2-{[4-(3-甲氧基丙氧基)-3-甲基-1-氧代吡啶-2-基]甲磺?;鶀-1H-苯并咪唑)
|
PCL-#-Chp0445-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
117976-47-3 |
50mg
|
咨詢
|
咨詢 |
PCL |
雷貝拉唑鈉雜質(zhì)Ⅱ(2-{[4-(3-甲氧基丙氧基)-3-甲基-1-氧代吡啶-2-基]甲磺?;鶀-1H-苯并咪唑)
|
PCL-#-Chp0445-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
117976-47-3 |
25mg
|
咨詢
|
咨詢 |
PCL |
雷貝拉唑鈉雜質(zhì)Ⅰ(2-{[4-(3-甲氧基丙氧基)-3-甲基-1-氧代吡啶-2-基]甲磺?;鶀-1H-苯并咪唑 )
|
PCL-#-Chp0444-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
924663-37-6 |
50mg
|
咨詢
|
咨詢 |
PCL |
雷貝拉唑鈉雜質(zhì)Ⅰ(2-{[4-(3-甲氧基丙氧基)-3-甲基-1-氧代吡啶-2-基]甲磺?;鶀-1H-苯并咪唑 )
|
PCL-#-Chp0444-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
924663-37-6 |
25mg
|
咨詢
|
咨詢 |
PCL |
碘海醇雜質(zhì)Ⅲ(5-硝基 N,N’-雙-(2,3-二羥苯基)-1,3—苯二甲酰胺)
|
PCL-#-Chp0443-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
76820-34-3 |
50mg
|
咨詢
|
咨詢 |
PCL |
碘海醇雜質(zhì)Ⅲ(5-硝基 N,N’-雙-(2,3-二羥苯基)-1,3—苯二甲酰胺)
|
PCL-#-Chp0443-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
76820-34-3 |
25mg
|
咨詢
|
咨詢 |
PCL |